Patty Donnelly, PhD

Vice President, Global Quality - Research and Development
Eli Lilly and Company
 

Patty Donnelly has a breadth of experience in drug discovery and development. She has held a variety of roles within the pharmaceutical industry over her 24-year career, and currently is the Vice President, Global Quality - Research & Development, at Eli Lilly and Company. Patty has led numerous drug development programs and Clinical Development and Quality functions. She also has played key leadership roles in collaborations involving in-/out-licensing of investigational drugs, strategic biotech acquisitions, and partnerships with contract research organizations. She earned her doctorate in Pharmacology and Toxicology from Queen’s University at Kingston, Ontario, Canada.